Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

NCT00196885 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-06-20

No results posted yet for this study

Summary

The purpose of the study is to tests the hypothesis, that N-acetylcysteine (a thiol-antioxidant)improves the exercise training effect on cancer patients that experience weight loss (cachexia) as assessed by muscle mass and function as well as histomorphology.

Conditions

Interventions

DRUG

N-acetylcysteine

Sponsors & Collaborators

  • Heidelberg University

    collaborator OTHER
  • German Cancer Research Center

    lead OTHER

Principal Investigators

  • Wulf Hildebrandt, MD · German Cancer Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-12-31
Completion
2006-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196885 on ClinicalTrials.gov